(Created page with "{{Infobox drug reference | trade_names = | drug_class = | drug_class_color = | uses = | contraindications = | routes = | dosage = }} Provide a brief summary of this dr...")
 
m (Added embedded dosage calculation)
Line 2: Line 2:
| trade_names =  
| trade_names =  
| drug_class =  
| drug_class =  
| drug_class_color =  
| drug_class_color = cardiovascular_agonist
| uses =  
| uses =  
| contraindications =  
| contraindications =  
| routes =  
| routes = IV
| dosage =  
| dosage =  
| dosage_calculation = dopamine
}}
}}



Revision as of 00:49, 30 March 2022

Dopamine
Clinical data
Routes of administration

IV

Dosage
Adult dosing
  • 2-50 mcg/kg/min IV
Indication 
Hypotension
Route 
Intravenous

  • Predominant receptor activation is dose-dependent:
    • <5 mcg/kg/min: Dopaminergic
    • 5-10 mcg/kg/min: β-1 adrenergic
    • >10 mcg/kg/min: α-1 adrenergic
  • Low-dose dopamine should not be used for renal protective effect

  1. Hollenberg SM. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med. 2011 Apr 1;183(7):847-55. doi: 10.1164/rccm.201006-0972CI. Epub 2010 Nov 19. PMID: 21097695.
  2. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000 Dec 23-30;356(9248):2139-43. doi: 10.1016/s0140-6736(00)03495-4. PMID: 11191541.
Pharmacodynamics
Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References